Solesence, Inc. Common Stock
NASDAQ:SLSNHousehold & Personal Products
+$0.05 today
- Market cap
- $115.86M
- Beta
- 1.24
- P/E (TTM)
- 99.5
- EPS (TTM)
- $0.01
Volume 0.30M
Average 0.04M
SLSN EBITDA Margin
EBITDA as a percentage of revenue.
Solesence, Inc. Common StockNASDAQ: SLSN
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin narrows to -1.5%
EBITDA Margin was -1.5% in Q1 FY2026, down 4.8 pp from a year earlier. On a trailing-twelve-month basis it was 5.0%, down 4.1 pp year over year. Over 3 fiscal years it widened by 10.5 pp.
Context
- EBITDA Margin widened in 1 of the last 3 fiscal years.
Sources:Income StatementText generated from reported figures; not investment advice.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 5.9%
- Year-over-year change
- -5.6pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.9% | -5.6pp |
| FY2024 | 2024-12-31 | 11.6% | +19.1pp |
| FY2023 | 2023-12-31 | -7.5% | -3.0pp |
| FY2022 | 2022-12-31 | -4.5% | -18.0pp |
| FY2021 | 2021-12-31 | 13.5% | — |
EBITDA Margin vs competitors
How SLSN compares with its peers on the latest reported figures
- SLSN's LTM Mar 2026 EBITDA Margin of 5.0% is the 6th highest of the 8 companies compared; the peer median is 10.2%.
- Its year-over-year change of -4.1 pp is the 5th highest of 7, against a peer median of +0.4 pp.
- Over three fiscal years its change of +10.5 pp compares with a peer median of -7.5 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 224.4% | +303.0 pp | -44.4 pp | |
| LTM Mar 2026 | 14.9% | +13.8 pp | -9.4 pp | |
| LTM Mar 2026 | 12.0% | -8.3 pp | -7.5 pp | |
| LTM Mar 2026 | 10.2% | -0.2 pp | +5.3 pp | |
| LTM Mar 2026 | 9.1% | +1.0 pp | +1.7 pp | |
SLSNSolesence, Inc. Common Stock | LTM Mar 2026 | 5.0% | -4.1 pp | +10.5 pp |
AFRIForafric Global PLC | LTM Jun 2024 | 2.8% | — | +3.0 pp |
| LTM Apr 2026 | -30.3% | -35.0 pp | -13.0 pp | |
| Peer median (excluding SLSN) | 10.2% | +0.4 pp | -7.5 pp | |
Competitors are the stored peer set for SLSN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 29.48M | 37.32M | 37.3M | 52.35M | 62.06M |
| Cost of Revenue | 20.79M | 28.96M | 29.47M | 36.16M | 46.04M |
| Gross Profit | 8.69M | 8.36M | 7.83M | 16.19M | 16.03M |
| Gross Margin | 29.5% | 22.4% | 21.0% | 30.9% | 25.8% |
| Research & Development | 2.24M | 3.04M | 3.84M | 3.84M | 4.08M |
| Selling, General & Admin | 3.9M | 7.58M | 7.53M | 7.22M | 10.38M |
| Operating Expenses | 6.13M | 10.62M | 11.37M | 11.06M | 14.46M |
| Depreciation & Amortization | 454K | 567K | 742K | 928K | 897K |
| EBITDA | 3.97M | (1.69M) | (2.8M) | 6.06M | 3.69M |
| EBITDA Margin | 13.5% | -4.5% | -7.5% | 11.6% | 5.9% |
| Operating Income | 2.56M | (2.26M) | (3.55M) | 5.13M | 1.57M |
| Operating Margin | 8.7% | -6.1% | -9.5% | 9.8% | 2.5% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.15M | 382K | 838K | 670K | 931K |
| Other Income / Expenses | (202K) | (382K) | (838K) | (670K) | 291K |
| Income Before Tax | 2.36M | (2.64M) | (4.38M) | 4.46M | 1.86M |
| Pre-Tax Margin | 8.0% | -7.1% | -11.8% | 8.5% | 3.0% |
| Income Tax Expense | 37K | (17K) | 6K | 227K | 73K |
| Net Income | 2.32M | (2.62M) | (4.39M) | 4.24M | 1.79M |
| Net Margin | 7.9% | -7.0% | -11.8% | 8.1% | 2.9% |
| EPS (Basic) | 0.05 | (0.05) | (0.09) | 0.07 | 0.03 |
| EPS (Diluted) | 0.05 | (0.05) | (0.09) | 0.07 | 0.02 |
| Weighted Avg Shares | 45.02M | 49.12M | 49.56M | 62.35M | 70.34M |
| Weighted Avg Shares (Diluted) | 47.04M | 49.12M | 49.56M | 65.03M | 72.58M |
Solesence, Inc. Common Stock
NASDAQ:SLSN
Intrinsic Alpha fair value
Locked
Current Price
$1.64
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.